Avandamet Bioequivalence Study Brazil - Fed Administration

NCT01332071 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Rosiglitazone Maleate + Metformin 2 miligrams (mg) + 500 mg
DRUG: Rosiglitazone Maleate + Metformin 4 miligrams (mg) + 1000 mg

Sponsor

GlaxoSmithKline